-
Full Article (HTML) (8) -
Full Article (PDF) (2)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2325)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 14, 2019 (publication date) through Jan 27, 2020
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Nele Brusselaers, Jesper Lagergren, Lars Engstrand. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer. Cancer Epidemiology 2019; 62: 101585 doi: 10.1016/j.canep.2019.101585
|
| 2 |
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. Journal of Gastroenterology 2019; doi: 10.1007/s00535-019-01652-z
|
| 3 |
Enrico Pierluigi Spugnini, Stefano Fais. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors. Expert Opinion on Therapeutic Patents 2020; 30(1): 15 doi: 10.1080/13543776.2020.1704733
|
| 4 |
Andrea Nuzzo, James R. Brown. The Microbiome Factor in Drug Discovery and Development. Chemical Research in Toxicology 2020; 33(1): 119 doi: 10.1021/acs.chemrestox.9b00333
|